Literature DB >> 26595536

Inherited disorders of bilirubin clearance.

Naureen Memon1, Barry I Weinberger2, Thomas Hegyi1, Lauren M Aleksunes3.   

Abstract

Inherited disorders of hyperbilirubinemia may be caused by increased bilirubin production or decreased bilirubin clearance. Reduced hepatic bilirubin clearance can be due to defective (i) unconjugated bilirubin uptake and intrahepatic storage, (ii) conjugation of glucuronic acid to bilirubin (e.g., Gilbert syndrome, Crigler-Najjar syndrome, Lucey-Driscoll syndrome, breast milk jaundice), (iii) bilirubin excretion into bile (Dubin-Johnson syndrome), or (iv) conjugated bilirubin re-uptake (Rotor syndrome). In this review, the molecular mechanisms and clinical manifestations of these conditions are described, as well as current approaches to diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26595536      PMCID: PMC4821713          DOI: 10.1038/pr.2015.247

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  74 in total

1.  Population studies on Gilbert's syndrome.

Authors:  D Owens; J Evans
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

2.  Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age eighteen.

Authors:  T F Blaschke; P D Berk; B F Scharschmidt; J R Guyther; J M Vergalla; J G Waggoner
Journal:  Pediatr Res       Date:  1974-05       Impact factor: 3.756

3.  Inhibition of bilirubin conjugation in rat liver slices by free fatty acids, with relevance to the problem of breast milk jaundice.

Authors:  B R Bevan; J B Holton
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

Review 4.  Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity.

Authors:  I M Arias; L M Gartner; M Cohen; J B Ezzer; A J Levi
Journal:  Am J Med       Date:  1969-09       Impact factor: 4.965

5.  Constitutional unconjugated hyperbilirubinaemia.

Authors:  J M Metreau; D Dhumeaux; C Gisselbrecht; A M Preaux; P Berthelot
Journal:  Lancet       Date:  1977-06-18       Impact factor: 79.321

6.  Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy.

Authors:  W S Lee; P J McKiernan; S V Beath; M A Preece; D Baty; D A Kelly; B Burchell; D J Clarke
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

7.  Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver.

Authors:  S Onishi; N Kawade; S Itoh; K Isobe; S Sugiyama
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

8.  beta-Glucuronidase and hyperbilirubinaemia in breast-fed and formula-fed babies.

Authors:  G R Gourley; R A Arend
Journal:  Lancet       Date:  1986-03-22       Impact factor: 79.321

9.  Bilirubin and paranitrophenol glucuronyl transferase activities of the liver in patients with Gilbert's syndrome An attempt at a biochemical breakdown of the Gilbert's syndrome.

Authors:  C Auclair; J Hakim; P Boivin; H Troube; J Boucherot
Journal:  Enzyme       Date:  1976

Review 10.  Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties.

Authors:  Bruno Hagenbuch; Peter J Meier
Journal:  Pflugers Arch       Date:  2003-10-25       Impact factor: 3.657

View more
  29 in total

1.  Determination of chemical-disease risk values to prioritize connections between environmental factors, genetic variants, and human diseases.

Authors:  Marissa B Kosnik; David M Reif
Journal:  Toxicol Appl Pharmacol       Date:  2019-07-16       Impact factor: 4.219

Review 2.  Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human disease.

Authors:  Celia N Sanchez-Dominguez; Hugo L Gallardo-Blanco; Mauricio A Salinas-Santander; Rocio Ortiz-Lopez
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

3.  Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Authors:  Wei-Wei Li; Yan Yang; Qi-Gang Dai; Li-Li Lin; Tong Xie; Li-Li He; Jia-Lei Tao; Jin-Jun Shan; Shou-Chuan Wang
Journal:  Metabolomics       Date:  2018-06-21       Impact factor: 4.290

4.  PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics.

Authors:  Maria Alvarellos; Chantal Guillemette; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2018-05       Impact factor: 2.089

5.  Murine epithelial sodium (Na+) channel regulation by biliary factors.

Authors:  Xue-Ping Wang; Seohyun Janice Im; Deidra M Balchak; Nicolas Montalbetti; Marcelo D Carattino; Evan C Ray; Ossama B Kashlan
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

6.  [Role of pyroptosis in bilirubin-induced microglial injury].

Authors:  Hong-Mei Huang; Chun-Mei He; Si-Yu Li; Yan Zhang; Zi-Yu Hua
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

7.  Literature review and report of three cases of Dubin-Johnson syndrome related to ABCC2 gene mutations in children.

Authors:  Sheng-Jie You; Ying-Xue Sun; Jing Zhang; Qiang He; Xiao-Ming Wu; Yan Hu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 8.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

9.  Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: The discovery of seven novel variants in the Chinese population.

Authors:  Leilei Gu; Yue Han; Donghua Zhang; Qiming Gong; Xinxin Zhang
Journal:  Mol Genet Genomic Med       Date:  2022-04-14       Impact factor: 2.473

Review 10.  Ethnopharmacological Approaches for Therapy of Jaundice: Part I.

Authors:  Devesh Tewari; Andrei Mocan; Emil D Parvanov; Archana N Sah; Seyed M Nabavi; Lukasz Huminiecki; Zheng Feei Ma; Yeong Yeh Lee; Jarosław O Horbańczuk; Atanas G Atanasov
Journal:  Front Pharmacol       Date:  2017-08-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.